Hummus from the Kitchen of the American Institute for Cancer Research

In their continuing effort to promote cancer-preventive lifestyle choices, the American Institute for Cancer Research and author Dana Jacobi create delicious and healthy dishes like this one, hummus.

In the Arabic language, the word 'hummus' means 'chickpeas', and the hummus we eat is actually translated as 'chickpeas with tahini.'

Humans have been eating chickpeas (legumes) for thousands of years, and this makes sense because chickpeas are a great source of protein and fiber.

The AICR also says that,

Hummus is commonly served as a dip with pita bread, but it is also great with raw vegetables, like carrots, celery and bell pepper slices. Serve hummus as a sandwich on mini whole-wheat pita with sliced tomatoes and cucumbers layered on top. This pairs well with a nice hot lentil soup.

Hummus

  • 2 (15-oz.) cans no-salt-added chickpeas, drained, liquid reserved
  • 5 garlic cloves, minced
  • 1/3 cup tahini
  • 5 Tbsp. freshly squeezed lemon juice
  • 2 Tbsp. chickpea liquid
  • 1 Tbsp. extra virgin olive oil
  • Salt to taste
  • Paprika or parsley sprigs for garnish, optional

Instructions

Place all ingredients except salt and optional garnish in food processor. Process until mixture is coarsely puréed. Add salt to taste. Serve at room temperature or chilled. Garnish with a dash of paprika or parsley sprigs.

Makes 10 servings. Per Serving: ¼ cup

Per serving: 144 calories, 7 g total fat (1 g saturated fat), 16 g carbohydrate, 6 g protein, 5 g dietary fiber, 13 mg sodium.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap